Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Calcium for Pre-Eclampsia Prevention (CPEP) [Phase 3]
Phase 3 NICHD trial CPEP evaluating calcium supplementation to prevent pre-eclampsia in pregnancy has completed. The study encompasses preve…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Improving Heart Health in Appalachia [NA]
This clinical trial update notes the completion of a study aimed at improving heart health in Appalachian populations, focusing on obesity, …
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension.
This completed clinical trial evaluates biological and electrocardiographic biomarkers for risk stratification in hypertension.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension [NA]
A completed clinical trial evaluating Vitamin D therapy in individuals at high risk of hypertension.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans [NA]
This update reports the completion of a clinical trial evaluating a health-literacy program intended to improve blood pressure control among…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease [NA]
A clinical trial evaluating exercise as an adjunct therapy to reduce blood pressure in adults with chronic kidney disease and hypertension h…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome [Phase 4]
The document reports a Phase 4 clinical trial update from Novartis focused on reducing overall cardiovascular risk in patients with metaboli…
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness [NA]
This document provides an update on a clinical trial exploring strategies to prevent cardiovascular and renal events by targeting arterial s…
-
FDA approval · 2017-02-27FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Cardura XL (doxazosin mesylate) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Effects of Blackberry-derived Polyphenols on Cardiovascular Risk in Adults [NA]
This update reports on a completed clinical trial evaluating the effects of blackberry-derived polyphenols on cardiovascular risk in adults …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Aerobic Physical Training and Heart Rate Variability in Hypertersion [NA]
This completed clinical trial from the University of Campinas evaluated the impact of aerobic physical training on heart rate variability in…
-
CLINICAL_TRIALS research · 2017-02-27Clinical Trial Update: Salt-sensitive Hypertension Study in Lantian County
Clinical trial update on a salt-sensitive hypertension study in Lantian County conducted by the First Affiliated Hospital Xi'an Jiaotong Uni…
-
FDA approval · 2017-02-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide manufactured …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy [Phase 4]
Phase 4 trial comparing valsartan-based versus amlodipine-based treatment strategies in adults with stage 1/2 hypertension or uncontrolled h…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome [Phase 3]
Phase 3 trial assessing the effect of valsartan on lipid subfractions in adults with hypertension and metabolic syndrome; the study status i…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Community-based Management of Hypertension in Nepal [NA]
The document reports that the University of Aarhus–sponsored community-based hypertension management trial in Nepal has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Antiproteinuric Effect of Valsartan and Lisinopril [Phase 4]
This Phase 4 trial assesses the antiproteinuric effects of combining valsartan (ARB) and lisinopril (ACE inhibitor) in patients with hyperte…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor
This document reports that a clinical trial evaluating a non-invasive ECG-assisted blood pressure monitor was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia [Phase 3]
A completed Phase 3 trial evaluating a fixed combination of valsartan 320 mg and simvastatin 80 mg versus monotherapies for hypertension and…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women [Phase 4]
Phase 4 trial comparing valsartan to atenolol on exercise capacity in hypertensive overweight postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension [Phase 4]
Phase 4 trial evaluating whether the combination of amlodipine and benazepril reduces left ventricular hypertrophy in patients with high-ris…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy and safety of aliskiren/amlodipine, with or without hydrochlorothiazide, in patients with Stage II hyp…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy [Phase 4]
A national multicentre Phase 4 trial evaluated the efficacy of a fixed-dose combination of valsartan and amlodipine in patients with primary…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg [Phase 4]
Phase 4 trial evaluating efficacy and safety when switching from candesartan 32 mg to a fixed-dose olmesartan 40 mg/amlodipine 10 mg combina…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of VAH631 in Patients With Essential Hypertension (Factorial Study) [Phase 3]
Phase 3 factorial study update of VAH631 in essential hypertension; the trial sponsored by Novartis has completed.